Incannex forms joint venture with Mind Medicine Australia

Incannex (IXHL) Healthcare announces entering into a 50:50 joint venture with Mind Medicine Australia, MMA, to operate a psychedelic-assisted therapies services clinic in Melbourne. Incannex CEO Joel Latham commented, “This joint venture is a significant milestone around our strategy to bring psychedelic-assisted therapies to those who need them most. Working alongside a leading organization in this space, we expect to build the clinical infrastructure necessary to deliver safe, effective, and scalable treatment options. Importantly, this initiative not only strengthens our presence in a high-growth therapeutic sector but also aligns with our long-term commitment to generating opportunities for sustainable long-term shareholder value.” The new entity, Mind Medicine Australia Clinics, represents a strategic advancement in Incannex’s commercialization model. The joint venture will deliver a fully integrated suite of services including clinical operations, governance, medicine supply, medical oversight, and marketing support to a growing network of aligned Authorised Prescribers across Australia.